Please login to the form below

Not currently logged in
Email:
Password:

tobramycin

This page shows the latest tobramycin news and features for those working in and with pharma, biotech and healthcare.

CURx buys rights to Gilead’s lung infection drug

CURx buys rights to Gilead’s lung infection drug

CURx buys rights to Gilead’ s lung infection drug. Agrees deal for fosfomycin/tobramycin combination. ... Dinu Sen, CEO and founder of CURx, said that fosfomycin/tobramycin for inhalation also has potential beyond the specific Pseudomonas aeruginosa

Latest news

More from news
Approximately 4 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

The Holy Grail of HCP Access
This is the data you need to gain access....
No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....

Infographics